Potential role of lipoxin in the management of COVID-19: a narrative review

被引:0
|
作者
Gaber El-Saber Batiha
Ali I. Al-Gareeb
Engy Elekhnawy
Hayder M. Al-kuraishy
机构
[1] Damanhour University,Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine
[2] Al-Mustansiriyah University,Department of Pharmacology, Toxicology and Medicine, College of Medicine
[3] Tanta University,Pharmaceutical Microbiology Department, Faculty of Pharmacy
来源
Inflammopharmacology | 2022年 / 30卷
关键词
Arachidonic acid; COVID-19; Inflammation; Lipoxins; SARS-CoV-2;
D O I
暂无
中图分类号
学科分类号
摘要
Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection leads to the development of coronavirus disease 2019 (COVID-19), which causes endothelial dysfunction (ED), oxidative stress (OS), and inflammatory disorders. These changes cause hypoxia and cytokine storm with the development of cardio-pulmonary complications. Bioactive lipids and other polyunsaturated fatty acids participate in a vital role in the SARS-CoV-2 infection process. One of these mediators is the anti-inflammatory compound, lipoxin (LX). LXs are produced from arachidonic acid (AA) by collaboration between 5-lipoxygenase (5-LO) and 12–15 LO during cell interactions. Thus, our goal was to review the probable role of LXs in COVID-19 regarding the effects of LXs on the inflammatory signaling pathways that are linked with COVID-19 pathogenesis and complications.
引用
收藏
页码:1993 / 2001
页数:8
相关论文
共 50 条
  • [1] Potential role of lipoxin in the management of COVID-19: a narrative review
    Batiha, Gaber El-Saber
    Al-Gareeb, Ali, I
    Elekhnawy, Engy
    Al-Kuraishy, Hayder M.
    INFLAMMOPHARMACOLOGY, 2022, 30 (06) : 1993 - 2001
  • [2] Management of Somatization in COVID-19: A Narrative Review
    Wankhade, Dhanashree
    Anjankar, Ashish P.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [3] Potential Treatments for COVID-19; a Narrative Literature Review
    Rismanbaf, Ali
    ARCHIVES OF ACADEMIC EMERGENCY MEDICINE, 2020, 8 (01)
  • [4] Potential neurological manifestations of COVID-19: a narrative review
    Pergolizzi, Joseph V., Jr.
    Raffa, Robert B.
    Varrassi, Giustino
    Magnusson, Peter
    LeQuang, Jo Ann
    Paladini, Antonella
    Taylor, Robert
    Wollmuth, Charles
    Breve, Frank
    Chopra, Maninder
    Nalamasu, Rohit
    Christo, Paul J.
    POSTGRADUATE MEDICINE, 2022, 134 (04) : 395 - 405
  • [5] Comprehensive physiotherapy management in covid-19 - a narrative review
    Kalirathinam, Deivendran
    Guruchandran, Raj
    Subramani, Prabhakar
    SCIENTIA MEDICA, 2020, 30 (01)
  • [6] The Role of POCUS to Face COVID-19: A Narrative Review
    Sartini, Stefano
    Ferrari, Lorenzo
    Cutuli, Ombretta
    Castellani, Luca
    Cristina, Maria Luisa
    Arboscello, Eleonora
    Sartini, Marina
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)
  • [7] The potential role of telemedicine in the infectious disease pandemic with an emphasis on COVID-19: A narrative review
    Shokri, Fazlollah
    Bahrainian, Sara
    Tajik, Fatemeh
    Rezvani, Elaheh
    Shariati, Aref
    Nourigheimasi, Shima
    Shahrebabaki, Elahe Saberi
    Ebrahimi, Maryam
    Shamoon, Farhan
    Heidary, Mohsen
    HEALTH SCIENCE REPORTS, 2023, 6 (01)
  • [8] COVID-19 and multiorgan failure: A narrative review on potential mechanisms
    Mokhtari, Tahmineh
    Hassani, Fatemeh
    Ghaffari, Neda
    Ebrahimi, Babak
    Yarahmadi, Atousa
    Hassanzadeh, Ghomareza
    JOURNAL OF MOLECULAR HISTOLOGY, 2020, 51 (06) : 613 - 628
  • [9] COVID-19 and multiorgan failure: A narrative review on potential mechanisms
    Tahmineh Mokhtari
    Fatemeh Hassani
    Neda Ghaffari
    Babak Ebrahimi
    Atousa Yarahmadi
    Ghomareza Hassanzadeh
    Journal of Molecular Histology, 2020, 51 : 613 - 628
  • [10] Repurposing of antibiotics for clinical management of COVID-19: a narrative review
    Yacouba, Abdourahamane
    Olowo-Okere, Ahmed
    Yunusa, Ismaeel
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2021, 20 (01)